These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
329 related items for PubMed ID: 6105003
21. Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs. Hefti F, Enz A, Melamed E. Neuropharmacology; 1985 Jan; 24(1):19-23. PubMed ID: 2858830 [Abstract] [Full Text] [Related]
22. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine. Roger LJ, Breese GR, Morell P. Brain Res; 1980 Sep 15; 197(1):95-112. PubMed ID: 6156743 [Abstract] [Full Text] [Related]
23. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--I. Behavioural, neurochemical and histological characterization of the lesion. Sirinathsinghji DJ, Heavens RP, Richards SJ, Beresford IJ, Hall MD. Neuroscience; 1988 Oct 15; 27(1):117-28. PubMed ID: 3264391 [Abstract] [Full Text] [Related]
24. Induction of dopaminergic supersensitivity after a single dose of the neuroleptic isofloxythepin. Valchár M, Metysová J, Chlebounová J, Dlabac A. Psychopharmacology (Berl); 1982 Oct 15; 76(4):381-4. PubMed ID: 6126896 [Abstract] [Full Text] [Related]
25. Effects of anaesthetics on the loss of nigrostriatal dopaminergic neurons by 6-hydroxydopamine in rats. Datla KP, Zbarsky V, Dexter DT. J Neural Transm (Vienna); 2006 May 15; 113(5):583-91. PubMed ID: 16082506 [Abstract] [Full Text] [Related]
26. Chronic L-DOPA-pretreatment of rats: an electrophysiological and biochemical study in the basal ganglia. Jackson DM, Walters JR, Miller LP. Brain Res; 1982 Nov 04; 250(2):271-82. PubMed ID: 6129029 [Abstract] [Full Text] [Related]
27. Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum. Savasta M, Dubois A, Feuerstein C, Manier M, Scatton B. Neurosci Lett; 1987 Feb 24; 74(2):180-6. PubMed ID: 2883609 [Abstract] [Full Text] [Related]
28. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine. Matsuura K, Makino H, Ogawa N. Exp Neurol; 1997 Aug 24; 146(2):526-35. PubMed ID: 9270064 [Abstract] [Full Text] [Related]
29. Biochemical changes accompanying unilateral 6-hydroxydopamine lesions in the rat substantia nigra. Saavedra JM, Setler PE, Kebabian JW. Brain Res; 1978 Aug 04; 151(2):339-52. PubMed ID: 679013 [Abstract] [Full Text] [Related]
30. Two kinds of nigrostriatal asymmetry: relationship to dopaminergic drug sensitivity and 6-hydroxydopamine lesion effects in Long-Evans rats. Glick SD, Hinds PA, Baird JL. Brain Res; 1988 May 31; 450(1-2):334-41. PubMed ID: 3135915 [Abstract] [Full Text] [Related]
31. Oxytocin-conjugated saporin injected into the substantia nigra of male rats alters the activity of the nigrostriatal dopaminergic system: A behavioral and neurochemical study. Sanna F, Bratzu J, Angioni L, Pina Sorighe M, Cocco C, Argiolas A, Melis MR. Brain Res; 2021 Dec 15; 1773():147705. PubMed ID: 34744015 [Abstract] [Full Text] [Related]
32. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity. Staunton DA, Magistretti PJ, Shoemaker WJ, Deyo SN, Bloom FE. Brain Res; 1982 Jan 28; 232(2):401-12. PubMed ID: 6322915 [Abstract] [Full Text] [Related]
33. Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding. Creese I, Snyder SH. Eur J Pharmacol; 1979 Jun 15; 56(3):277-81. PubMed ID: 38973 [Abstract] [Full Text] [Related]
34. Effect of chronic apomorphine on the development of denervation supersensitivity. Robin M, Forler C, Palfreyman MG. Pharmacol Biochem Behav; 1985 Apr 15; 22(4):547-51. PubMed ID: 3921992 [Abstract] [Full Text] [Related]
35. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Robinson TE, Whishaw IQ. Brain Res; 1988 May 31; 450(1-2):209-24. PubMed ID: 3135914 [Abstract] [Full Text] [Related]
36. Increased striatal glutamate decarboxylase after lesions of the nigrostriatal pathway. Vincent SR, Nagy JI, Fibiger HC. Brain Res; 1978 Mar 17; 143(1):168-73. PubMed ID: 24494 [No Abstract] [Full Text] [Related]
37. Dopamine release in rat striatum: physiological coupling to tyrosine supply. During MJ, Acworth IN, Wurtman RJ. J Neurochem; 1989 May 17; 52(5):1449-54. PubMed ID: 2496199 [Abstract] [Full Text] [Related]
38. Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA. Hefti F, Melamed E, Sahakian BJ, Wurtman RJ. Pharmacol Biochem Behav; 1980 Feb 17; 12(2):185-8. PubMed ID: 7189592 [Abstract] [Full Text] [Related]
39. Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra. Dentresangle C, Le Cavorsin M, Savasta M, Leviel V. Brain Res; 2001 Mar 02; 893(1-2):178-85. PubMed ID: 11223005 [Abstract] [Full Text] [Related]
40. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage. Zhang WQ, Tilson HA, Nanry KP, Hudson PM, Hong JS, Stachowiak MK. Brain Res; 1988 Oct 04; 461(2):335-42. PubMed ID: 3141002 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]